Citizens JMP lowered the firm’s price target on Jamf Holding (JAMF) to $27 from $30 and keeps an Outperform rating on the shares. Jamf posted ...
Citizens JMP raised the firm’s price target on Argenx (ARGX) to $701 from $696 and keeps an Outperform rating on the shares. Argenx’s Q4 ...
C3 AI (NYSE: AI), the Enterprise AI application software company, today announced that C3 AI Chairman and CEO Thomas M. Siebel will participate in a fireside chat at The Citizens JMP Technology ...
8d
Hosted on MSNCitizens JMP downgrades Fiverr on volume contraction in 2025Citizens JMP last night downgraded Fiverr (FVRR) to Market Perform from Outperform without a price target The company ...
JMP Securities reaffirmed their market perform rating on shares of Datadog (NASDAQ:DDOG – Free Report) in a research report ...
1d
TipRanks on MSNTaboola downgraded to Market Perform from Outperform at Citizens JMPCitizens JMP analyst Andrew Boone downgraded Taboola (TBLA) to Market Perform from Outperform. Published first on TheFly – the ultimate source for ...
will participate in a fireside chat at the Citizen JMP Technology Conference on Tuesday, March 4th, 2025. This press release contains “forward-looking statements,” which generally are ...
We recently compiled a list of the 12 AI News Investors Probably Missed. In this article, we are going to take a look at where CyberArk Software Ltd. (NASDAQ:CYBR) stands against the other AI stocks.
Gannett Co., Inc. (“Gannett”, “we”, “our”, or the “Company”) (NYSE: GCI) today announced that its Chairman and Chief Executive Officer, Michael Reed, ...
Ibotta (NYSE: IBTA), which operates the largest digital promotions network in North America, announced today that CEO and founder, Bryan Leach, will participate in a fireside chat at The Citizens JMP ...
JMP Securities raised the price targets on Cloudflare (NYSE:NET) and CyberArk Software (NASDAQ:CYBR), while highlighting an industry overview of cybersecurity stocks ahead of quarterly results.
JMP Securities reiterated their market outperform rating on shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) in a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results